Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2005
05/26/2005WO2005046452A2 A polypeptide complex that regulates cell cycle and anergy
05/26/2005WO2005046450A2 Method for diagnosis and treatment of pulmonary disorders
05/26/2005WO2005046434A2 Compositions and methods for diagnosing and treating mental disorders
05/26/2005WO2005046314A2 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes
05/26/2005WO2005031309A3 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways
05/26/2005WO2005030028A3 Methods for detecting presence of cellular constituents
05/26/2005WO2005026911A3 Apparatus and method for identifying therapeutic targets using a computer model
05/26/2005WO2005026738A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a9 (slc22a9)
05/26/2005WO2005024380A3 Method and system for assaying transferase activity
05/26/2005WO2005021786A8 A method of sequencing nucleic acids by ligation of labelled oligonucleotides
05/26/2005WO2005016246A3 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
05/26/2005WO2005010209A3 Method for the reverse transcription and/or amplification of nucleic acids
05/26/2005WO2005010048A3 Rg1 antibodies and uses thereof
05/26/2005WO2005009374A8 Ceramide dependent-stabilization of bace1
05/26/2005WO2005009363A3 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies
05/26/2005WO2005009217A3 Diagnosis of pre-cancerous conditions using pcdgf agents
05/26/2005WO2005005954A3 Method, composition and kit for detecting phosphatidylserine (ps) on cell membranes
05/26/2005WO2005003158A3 Compositions and methods for increasing bone mineralization
05/26/2005WO2005001137A3 Detection of high grade dysplasia in cervical cells
05/26/2005WO2004113570A3 Genotype test for dogs
05/26/2005WO2004113567A3 Improved heavymethyl assay for the methylation analysis of the gstpi gene
05/26/2005WO2004097372A9 Element-coded affinity tags
05/26/2005WO2004097039A3 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
05/26/2005WO2004097031A3 Methods for detecting methylated promoters based on differential dna methylation
05/26/2005WO2004094670A3 Multiplexed dna assays using structure-specific endonucleases
05/26/2005WO2004061126A3 Nucleic acid hybridization assay using bridging sequence
05/26/2005WO2004048542A3 Mapks as modifiers of the rac, axin, and beta-catenin pathways and methods of use
05/26/2005WO2004029747A3 Method for producing virtual chromosomes
05/26/2005WO2004027028A3 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
05/26/2005WO2004022719A3 Type 2 diabetes susceptibility genes
05/26/2005WO2003099846A3 System and method for screening for protease inhibitors and proteases
05/26/2005WO2003077841A3 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
05/26/2005US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
05/26/2005US20050114062 Method of reducing the effect of direct interference current in an electrochemical test strip
05/26/2005US20050114035 Method for binding site identification
05/26/2005US20050113569 Preparing an oligonucleotide; coupling a nucleoside to a support-bound nucleotide having a 5'-hydroxyl group, a nucleoside having a 5'-hydroxy protecting group and a 3'-functional group capable of linking to the 5'-hydroxyl group; removing the protecting group in the presence of dichloroacetic acid
05/26/2005US20050113408 Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
05/26/2005US20050113329 Contacing cell/body fluid with antibody which binds human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide; for inhibiting tumor growth; gene expression inhibition; immunization
05/26/2005US20050113326 Gene expression inhibition; connective tissue growth factor modulators; nucleosides, phosphorothioate/phosphodiester linkages; metabolic diseases, diabetes
05/26/2005US20050113303 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity
05/26/2005US20050113284 Drug for regenerating tissue and vessel and method therefor
05/26/2005US20050113273 Alkaline protease from bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease
05/26/2005US20050112882 Microfabricated elastomeric valve and pump systems
05/26/2005US20050112784 Analyte assay using particulate labels
05/26/2005US20050112783 Storage containers; robot positioning; applying electromagnetic radiation
05/26/2005US20050112781 4,7-dichlororhodamine dyes labeled polynucleotides
05/26/2005US20050112777 Regeneration of biosensors
05/26/2005US20050112770 Method for optical measurement of multi-stranded nucleic acid
05/26/2005US20050112769 Fluorescent tool in high throughput assay
05/26/2005US20050112756 Substrate with well; guide ; detective electrodes; measuring charge generated by electrolytic cells
05/26/2005US20050112754 Apparatus and method for amplifying a polynucleotide
05/26/2005US20050112753 Using a multistage plastic filter in common housing
05/26/2005US20050112752 Method for the purification of alphavirus replicon particles
05/26/2005US20050112744 Glucose dehydrogenase fusion proteins and their use in expression systems
05/26/2005US20050112743 Method of analyzing enzyme compositions with lipolytic, proteolytic and amylolytic activity
05/26/2005US20050112730 Nucleotide sequences which code for the opcA gene
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112718 Containing reducing chromogenic reagent; cell differentiation; colorimetric analysis
05/26/2005US20050112717 Using solution containing nitric oxide synthase for synthesis of nitrogen oxide ; adding guanylate cyclase and guanosine triphosphate which allow synthesis of cyclic guanosine, 3',5'-monophosphate; measurement amount of cyclic guanosine 3',5'-monophosphate using antibodies
05/26/2005US20050112716 NMR-solve method for rapid identification of bi-ligand drug candidates
05/26/2005US20050112715 Detection of herbicide; contacting compound with pectin esterase; detecting binding or absence thereof
05/26/2005US20050112712 Diagnostics based on tetrazolium compounds
05/26/2005US20050112710 Screening for ligand binding at specific target sites
05/26/2005US20050112709 Histone h3methyltransferase polypeptide
05/26/2005US20050112705 Detecting cancer perticularly of prostate gland
05/26/2005US20050112700 Concurrent determination activation of protein in cells; binding; fluid flow cytometry
05/26/2005US20050112696 Determination moderator of beta-secretase on proteins
05/26/2005US20050112692 Screening peptide library; incubation complexing
05/26/2005US20050112689 Systems and methods for statistically analyzing apparent CGH data anomalies and plotting same
05/26/2005US20050112687 Immobilization on solid support; heat resistance; quantitative analysis
05/26/2005US20050112686 Method for introducing molecules into biological samples
05/26/2005US20050112682 Green fluorescent fusion protein as diagnosis tool; quantitative analysis; colorimetic analysis
05/26/2005US20050112681 Isolated human transporter proteins, nucleic acid molecules encoding human, transporter proteins, and uses thereof
05/26/2005US20050112680 Gene sequence variances in genes related to folate metabolism having utility in determining the treatment of disease
05/26/2005US20050112678 Determination of gene copy number in test sample; calibration; amplification of gene indicates cancer
05/26/2005US20050112677 Substrate having oxide layer, method for detecting target material using the substrate, and optical sensor including the substrate
05/26/2005US20050112676 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography
05/26/2005US20050112675 Polypeptides gene expressed in fat tissue ; measurement concentration; using antibodies
05/26/2005US20050112671 Analyzing polymers; such as Dna, Rna; generating signals; using probe capable of hybridization
05/26/2005US20050112670 Chromosome state analysis
05/26/2005US20050112668 Determination sensitivity for development fat metabolism diosrders by comparison of gene expression levels
05/26/2005US20050112667 Microscope system and methods for intracellular studies
05/26/2005US20050112658 Using adsorptive porous membrane
05/26/2005US20050112657 Polymerase chain reactions; obtaining nucleotide sequences; incubation with primer; denaturing
05/26/2005US20050112656 Method for isolating and purifying nucleic acid, cartridge for isolating and purifying nucleic acid, and kit isolating and purifying nucleic acid
05/26/2005US20050112655 Detection of signal generated from binding label
05/26/2005US20050112653 Preservation material for analysis; encapsulation into plastic cards ; Dna profiles
05/26/2005US20050112652 Support overcoated with reagent; porous walls; multilayer; variations in refractive index ; applying activating light
05/26/2005US20050112651 Microarray comprising a substrate having two-dimensional grating and method of detecting target molecule by using the same
05/26/2005US20050112650 Binding to analytic compounds; probe for spectrometry; crosslinked polyurethane
05/26/2005US20050112649 Mixture of genetic, immunology anf toxin fingerprints
05/26/2005US20050112648 Genetic markers for pig backfat thickness
05/26/2005US20050112647 Amplifying target sequence in presence of duplex binding agent, polymerase and labeled primer/probe, recovering product and monitoring fluorescence; kits; solid phase synthesis; gene therapy
05/26/2005US20050112641 Protein mixture which confers antibiotic resistance
05/26/2005US20050112639 Propagating/replicating preferential nucleotide/gene sequences using circular plasmid; genetic engineering and heterologous gene expression
05/26/2005US20050112636 Detect sensitivity; multiple neotide sequences
05/26/2005US20050112635 Mass spectrometry; adding dendimer to sample; measurement; calibration
05/26/2005US20050112634 High density sequence detection methods and apparatus
05/26/2005US20050112632 Drug resistance to betal blockers; genotyping; transgenic rodents; detecting therapy
05/26/2005US20050112631 Using polymerase amplification to propagate target Dna